New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Caribou Biosciences, Inc.
CRBU
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

129M

Biotechnology

Next Earning date - 10 Mar 2025

129M

Biotechnology

Next Earning date - 10 Mar 2025

1.42USD

Shape-0.04 ( -2.74%)
Market Closed (as of Feb 06, 21:00 EDT)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-42%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

83%

Quote Panel

Shape
Updated February 7, 2025
1W 3.65 % 1M -17.44 % 3M -47.01 % 1Y -79.09 %

Key Metrics

Shape
  • Market Cap

    128.58M


  • Shares Outstanding

    90.55M


  • Share in Float

    79.16M


  • Dividende

    0


  • Earning Date

    10 Mar 2025


  • Price Target

    1.42


  • Average Volume

    1.59M


  • Beta

    2.263


  • Range

    1.3-8.33


  • Industry

    Biotechnology


  • Website

    https://cariboubio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CRBU

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10M

Shape401%

2025-Revenue

$1.86

Shape-389%

2025-EPS

$10M

Shape73%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

RBC Capital

initialise

Previous: Not converted

2022-02-18

Now: Outperform

H.C. Wainwright

initialise

Previous: Not converted

2021-11-30

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.44
vs -0.34

Q1.23

arrow
arrow

N/A

-0.46
vs -0.35

Q2.23

arrow
arrow

N/A

-0.48
vs -0.46

Q3.23

arrow
arrow

N/A

-0.12
vs -0.44

Q4.23

arrow
arrow

N/A

-0.39
vs -0.44

Q1.24

arrow
arrow

N/A

-0.46
vs -0.46

Q2.24

arrow
arrow

N/A

-0.42
vs -0.48

Q3.24

arrow
arrow

N/A

-0.38
vs -0.12

Q4.24

arrow
arrow

N/A

-0.42
vs -0.39

Q1.25

arrow
arrow

N/A

-0.44
vs -0.46

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+44%

3.7M  vs 2.6M

Q1.23

arrow
arrow

+31%

3.5M  vs 2.7M

Q2.23

arrow
arrow

-10%

3.8M  vs 4.2M

Q3.23

arrow
arrow

+616%

23.7M  vs 3.3M

Q4.23

arrow
arrow

-4%

3.6M  vs 3.7M

Q1.24

arrow
arrow

-31%

2.4M  vs 3.5M

Q2.24

arrow
arrow

-8%

3.5M  vs 3.8M

Q3.24

arrow
arrow

-91%

2M  vs 23.7M

Q4.24

arrow
arrow

-41%

2.1M  vs 3.6M

Q1.25

arrow
arrow

+17%

2.9M  vs 2.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-9%

-0.09
vs -0.08

Q1.23

arrow
arrow

-9%

-0.09
vs -0.09

Q2.23

arrow
arrow

-11%

-0.11
vs -0.09

Q3.23

arrow
arrow

-3%

-0.03
vs -0.11

Q4.23

arrow
arrow

-9%

-0.09
vs -0.03

Q1.24

arrow
arrow

-12%

-0.12
vs -0.09

Q2.24

arrow
arrow

-12%

-0.12
vs -0.12

Q3.24

arrow
arrow

-12%

-0.12
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

134

134
vs 117

15%

Q1.23

arrow
arrow

127

127
vs 134

-5%

Q2.23

arrow
arrow

126

126
vs 127

-1%

Q3.23

arrow
arrow

132

132
vs 126

5%

Q4.23

arrow
arrow

146

146
vs 132

11%

Q1.24

arrow
arrow

156

156
vs 146

7%

Q2.24

arrow
arrow

141

141
vs 156

-10%

Q3.24

arrow
arrow

130

130
vs 141

-8%

Earnings Growth

Latest News